Floatz logo

VITAMIN D

Neuroinflammation

Lagos State UniversitymixturePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Neuroinflammation cohort.

Asset / SponsorPhaseRating
Nivolumab
Stony Brook University
Phase 4BB
Dfn-15
Stony Brook University
Phase 4BB
Ashwagandha
Hasanuddin University
Phase 2B
Risperdal
Hasanuddin University
Phase 2B
Rvp-001
Reveal Pharmaceuticals Inc.
Phase 2B

View all 9 →

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →